Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Invest Dermatol. 2015 Jun 1;135(10):2544–2547. doi: 10.1038/jid.2015.196

Figure 1. Increased DRP1S616℗ is associated with the incidence of BRAFV600E melanoma.

Figure 1

(ad) IHC was performed to detect the status of BRAFV600E and DRP1S616℗ in benign nevi (68 samples, a), dysplastic nevi (40 samples, b), primary melanoma (187 samples, c), and nevi from patients that developed melanoma (46 samples, d). Fisher's Exact and Chi-Squared Tests determined statistical significance.